Bio Path Holdings Inc (BPTH)

Bio Path Holdings Inc (BPTH) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $10,059; returns 1 day +0.0%.

Bio-Path Holdings, Inc. (BPTH) is a clinical-stage biopharmaceutical company focused on developing RNAi nanoparticle drugs for cancer and other serious diseases. Their proprietary Liposomal DNA Antisense Technology (LDAT), called DNAbilize, delivers antisense DNA molecules directly into targeted cells.

Groups BPTH belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Healthcare
• Oncology
• Cancer Therapeutics
• Clinical Stage
• Life Sciences
• Drug Discovery

BPTH financial model: income statement, cash flow and balance sheet